PTEN and metastatic neoplasm: While these studies suggest that PTEN loss is an early event in PCa progression, others have found that the frequency of PTEN loss significantly increases in metastatic disease, with rates of 40% in mHSPC [4,71,75,78,79], approaching the frequency observed in mCRPC [59,60,80].